The Nonparametric Adaptive Grid Algorithm for Population Pharmacokinetic Modeling
暂无分享,去创建一个
Roger W. Jelliffe | Alona Kryshchenko | David S. Bayard | James V. Burke | Jay Bartroff | Robert Leary | Alan Schumitzky | Michael Neely | Walter M. Yamada | J. Burke | A. Schumitzky | J. Bartroff | R. Jelliffe | W. Yamada | D. Bayard | R. Leary | M. Neely | Alona Kryshchenko
[1] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[2] C. Carathéodory. Über den variabilitätsbereich der fourier’schen konstanten von positiven harmonischen funktionen , 1911 .
[3] J. Kiefer,et al. CONSISTENCY OF THE MAXIMUM LIKELIHOOD ESTIMATOR IN THE PRESENCE OF INFINITELY MANY INCIDENTAL PARAMETERS , 1956 .
[4] L. Baum,et al. A Maximization Technique Occurring in the Statistical Analysis of Probabilistic Functions of Markov Chains , 1970 .
[5] H. Faure. Discrépance de suites associées à un système de numération (en dimension s) , 1982 .
[6] B. Lindsay. The Geometry of Mixture Likelihoods: A General Theory , 1983 .
[7] A. Mallet. A maximum likelihood estimation method for random coefficient regression models , 1986 .
[8] Bennett L. Fox,et al. Algorithm 647: Implementation and Relative Efficiency of Quasirandom Sequence Generators , 1986, TOMS.
[9] Paul Bratley,et al. Algorithm 659: Implementing Sobol's quasirandom sequence generator , 1988, TOMS.
[10] A. Schumitzky. Nonparametric EM Algorithms for estimating prior distributions , 1991 .
[11] F Mentré,et al. Handling covariates in population pharmacokinetics. , 1994, International journal of bio-medical computing.
[12] Marie Davidian,et al. Nonlinear Models for Repeated Measurement Data , 1995 .
[13] L. Skovgaard. NONLINEAR MODELS FOR REPEATED MEASUREMENT DATA. , 1996 .
[14] J. Wakefield. The Bayesian Analysis of Population Pharmacokinetic Models , 1996 .
[15] Jack Dongarra,et al. LAPACK Users' guide (third ed.) , 1999 .
[16] R. Jelliffe. Goal-oriented, model-based drug regimens: setting individualized goals for each patient. , 2000, Therapeutic drug monitoring.
[17] D Bayard,et al. Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens. , 2000, Therapeutic drug monitoring.
[18] Roger W. Jelliffe,et al. An adaptive grid non-parametric approach to pharmacokinetic and dynamic (PK/PD) population models , 2001, Proceedings 14th IEEE Symposium on Computer-Based Medical Systems. CBMS 2001.
[19] Marie Davidian,et al. Nonlinear models for repeated measurement data: An overview and update , 2003 .
[20] Roger W. Jelliffe,et al. A Bayesian Approach to Tracking Patients Having Changing Pharmacokinetic Parameters , 2004, Journal of Pharmacokinetics and Pharmacodynamics.
[21] R. Savic,et al. Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions , 2009, The AAPS Journal.
[22] Djalil Chafaï,et al. Comparison of nonparametric methods in nonlinear mixed effects models , 2009, Comput. Stat. Data Anal..
[23] M. Karlsson,et al. A Population Pharmacokinetic Model of Gabapentin Developed in Nonparametric Adaptive Grid and Nonlinear Mixed Effects Modeling , 2009, Therapeutic drug monitoring.
[24] U. Holzgrabe,et al. New Semiphysiological Absorption Model To Assess the Pharmacodynamic Profile of Cefuroxime Axetil Using Nonparametric and Parametric Population Pharmacokinetics , 2009, Antimicrobial Agents and Chemotherapy.
[25] U. Holzgrabe,et al. Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers , 2010, Antimicrobial Agents and Chemotherapy.
[26] A. Prémaud,et al. Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches. , 2011, Pharmacological research.
[27] Alan Schumitzky,et al. Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R , 2012, Therapeutic drug monitoring.
[28] R. Koenker,et al. Convex Optimization in R , 2014 .
[29] R. Koenker,et al. Convex Optimization, Shape Constraints, Compound Decisions, and Empirical Bayes Rules , 2014 .